Evidence map›Paper›PMID 31016712›Full record

ArticleThe British journal of dermatology2020

Inherited MC1R variants in patients with melanoma are associated with better survival in women.

F E Lira, S Podlipnik, M Potrony, G Tell-Martí, N Calbet-Llopart, A Barreiro, C Carrera, J Malvehy, S Puig

Open access · hybridAbstract read
In one paragraph

Article in The British journal of dermatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Melanoma Risk and Melanocyte Biology.Acta dermato-venereologica · 2020
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

F E LiraDermatology Department, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
S PodlipnikDermatology Department, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.ORCID 0000-0003-4150-0522
M PotronyDermatology Department, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.ORCID 0000-0003-2766-0765
G Tell-MartíDermatology Department, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
N Calbet-LlopartDermatology Department, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
A BarreiroDermatology Department, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.ORCID 0000-0002-3387-3444
C CarreraDermatology Department, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.ORCID 0000-0003-1608-8820
J MalvehyDermatology Department, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
S PuigDermatology Department, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.ORCID 0000-0003-1337-9745
Instituto de Salud Carlos III · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESUniversitat de Barcelona · ES

Funding

AGAUR 2014_SGR_603 and 2017_SGR_1134 of the Catalan Government, SpainCERCA Programme/Generalitat de Catalunya a Research Grant from Fundación Científica de la Asociación Española Contra el Cáncer GCB15152978SOEN, SpainCIBER de Enfermedades Raras of the Instituto de Salud Carlos III, SpainEuropean Academy of Dermatology and Venereology PPRC-2017/19European Commission under the 6th Framework Programme LSHC-CT-2006-018702 (GenoMEL)Fondo de Investigaciones Sanitarias, Spain P.I.12/00840Fondo de Investigaciones Sanitarias, Spain PI15/00716Fondo de Investigaciones Sanitarias, Spain PI15/00956"Fondo Europeo de Desarrollo Regional (FEDER)"Fundació La Marató de TV3, 201331-30", Catalonia, SpainUnión Europea. Una manera de hacer Europa"
6 · The paper itself

Abstract

backgroundWomen have a better melanoma prognosis, and fairer skin/hair colour. The presence of inherited MC1R variants has been associated with a better melanoma prognosis, but its interaction with sex is unknown.

objectivesTo evaluate the relationship between germline MC1R status and survival, and determine any association with sex.

methodsThis was a cohort study including 1341 patients with melanoma from the Melanoma Unit of the Hospital Clinic of Barcelona, between January 1996 and April 2018. We examined known sex-related prognosis factors as they relate to features of melanoma and evaluated the sex-specific role of MC1R in overall and melanoma-specific survival. Hazard ratios (HRs) were calculated using univariate and multivariate Cox logistic regression.

resultsMen showed lower overall survival than women (P < 0·001) and the presence of inherited MC1R variants was not associated with better survival in our cohort. However, in women the presence of MC1R variants was associated with better overall survival in the multivariate analysis [HR 0·57, 95% confidence interval (CI) 0·38-0·85; P = 0·006] but not in men [HR 1·26, 95% CI 0·89-1·79; P = 0·185 (P-value for interaction 0·004)]. Analysis performed for melanoma-specific survival showed the same level of significance.

conclusionsInherited MC1R variants are associated with improved overall survival in women with melanoma but not in men. Intrinsic sex-dependent features can modify the role of specific genes in melanoma prognosis. We believe that survival studies of patients with melanoma should include analysis by sex and MC1R genotype. What's already known about this topic? Inherited MC1R variants have been associated with a better melanoma prognosis, but their interaction with sex is unknown. What does this study add? MC1R variants are related to better overall survival and melanoma-specific survival in women but not in men. What is the translational message? These differences between the sexes could imply future changes in melanoma follow-up and treatment strategies. This provides a basis for understanding the interaction between sex-related genes and germline variants in cancer.

Indexed as

MelanomaSkin NeoplasmsCohort StudiesFemaleGenetic Predisposition to DiseaseGenotypeHumansMaleReceptor, Melanocortin, Type 1Receptor, Melanocortin, Type 1

Identifiers

PMID31016712
PMCPMC6973087
OpenAlexW2942312716

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.